Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma (Q37227085)

19 August 2017

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma (English)

1 reference

19 August 2017

uterine carcinosarcoma

1 reference

Gloria S Huang

1

1 reference

19 August 2017

Lydia G Chiu

2

1 reference

19 August 2017

Juliana S Gebb

3

1 reference

19 August 2017

Marc J Gunter

4

1 reference

19 August 2017

Paniti Sukumvanich

5

1 reference

19 August 2017

Gary L Goldberg

6

1 reference

19 August 2017

Mark H Einstein

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

23 October 2007

1 reference

19 August 2017

1 reference

19 August 2017

107

1 reference

19 August 2017

3

1 reference

19 August 2017

513-517

1 reference

Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

New tumor markers: CA125 and beyond.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Preoperative serum CA-125 levels in treating endometrial cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

ERBB-2 gene overexpression and amplification in uterine sarcomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Preoperative CA 125 in endometrial cancer: is it useful?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Management of malignant, mixed mesodermal tumors of the uterus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696225

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

3 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

An evaluation of prognostic factors in uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

CA 125 levels in the preoperative assessment of advanced-stage uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Preoperative CA-125 levels predict poor prognostic pathologic features in early stage, FIGO grade 1 and 2 endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

CA 125 in gynecologic practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

CA 125: a useful marker in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Multiple serum markers in patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

CA 125 in serum and tumor from patients with uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

Tissue CA 125 and CA 19-9 in malignant, mixed mesodermal tumors of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.08.060

10.1016/J.YGYNO.2007.08.060

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference